Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    Namilumab Therapy Successful in Phase 1b Trial of Rheumatoid Arthritis
    March 15, 2017March 15, 2017

    Namilumab Therapy Successful in Phase 1b Trial of Rheumatoid Arthritis

    News, rheumatoid arthritis
    Namilumab, an investigational monoclonal antibody that binds with high affinity to GM-CSF, shows promise in the treatment of rheumatoid arthritis (RA), new research shows. GM-CSF stands for “granulocyte macrophage colony-stimulating ... Read more
    Cases of RA-associated Pulmonary Hypertension Show Need for Timely Diagnosis
    March 13, 2017March 13, 2017

    Cases of RA-associated Pulmonary Hypertension Show Need for Timely Diagnosis

    News, rheumatoid arthritis
    A timely diagnosis and effective treatment strategy for patients with pulmonary hypertension (PH) associated with rheumatoid arthritis (RA) can prevent right heart failure and significantly enhance their quality of life, ... Read more
    One in Four Americans Has Arthritis, Centers for Disease Control Reports
    March 10, 2017March 10, 2017

    One in Four Americans Has Arthritis, Centers for Disease Control Reports

    News
    One in every four Americans, or 54 million adults, has arthritis, according to a report from the Centers for Disease Control and Prevention (CDC). Twenty-four million adults must limit their activities due ... Read more
    Cytokine IL-21 Fuels Inflammation at Synovial Joints in RA Patients, Study Shows
    March 8, 2017March 8, 2017

    Cytokine IL-21 Fuels Inflammation at Synovial Joints in RA Patients, Study Shows

    News, rheumatoid arthritis
    Scientists have discovered a group of immune cells that cause joint inflammation in rheumatoid arthritis (RA) by secreting a factor called interleukin (IL)-21 — a potential new target for RA therapeutics. The study ... Read more
    Transcript of Interview with Rheumatologist, Dr. Ara Dikranian
    March 6, 2017March 6, 2017

    Transcript of Interview with Rheumatologist, Dr. Ara Dikranian

    News, rheumatoid arthritis
    Rheumatoid Arthritis News interviewed Dr. Ara Dikranian, a rheumatologist at the Cabrillo Center for Rheumatic Disease in El Cajon, California, about his experience in talking with rheumatoid arthritis (RA) patients concerning intimacy ... Read more
    In Interview, Rheumatologist Talks of Intimacy and Relationship Concerns of RA Patients
    March 6, 2017March 6, 2017

    In Interview, Rheumatologist Talks of Intimacy and Relationship Concerns of RA Patients

    News
    People with chronic diseases — of which  rheumatoid arthritis (RA) is one — need to talk openly with their doctors about topics that might be uncomfortable, such as their relationships ... Read more
    Olumiant Improved RA Symptoms Better Than Humira, Study Finds
    March 3, 2017March 3, 2017

    Olumiant Improved RA Symptoms Better Than Humira, Study Finds

    News, rheumatoid arthritis
    Olumiant (baricitinib) improved patients’ outcomes in the treatment of moderate-to-severe rheumatoid arthritis (RA), in comparison to placebo and a current standard treatment, Humira (adalimumab). These findings were published in The New England ... Read more
    Truxima, Biosimilar of Rituximab, Approved in Europe for RA and Certain Cancers
    March 1, 2017March 1, 2017

    Truxima, Biosimilar of Rituximab, Approved in Europe for RA and Certain Cancers

    News, rheumatoid arthritis
    The European Commission approved Truxima as a biosimilar of rituximab (sold under the brand name Rituxan in the U.S.) in the EU for all indications approved for rituximab, including rheumatoid arthritis ... Read more
    Pfizer Reports Positive Results for Xeljanz as RA Therapy, When Combined with Methotrexate
    February 22, 2017February 22, 2017

    Pfizer Reports Positive Results for Xeljanz as RA Therapy, When Combined with Methotrexate

    News, rheumatoid arthritis
    Pfizer recently announced top-line results from its Phase 3b/4 trial evaluating Xeljanz (tofacitinib citrate) as a treatment for moderate-to-severe rheumatoid arthritis (RA). The trial demonstrates that Xeljanz is more effective in ... Read more
    Vaccine Against Pneumococcal Pneumonia May Not Prevent Infection in RA Patients
    February 20, 2017February 20, 2017

    Vaccine Against Pneumococcal Pneumonia May Not Prevent Infection in RA Patients

    News, rheumatoid arthritis
    Vaccination against pneumococcal pneumonia may not protect patients with rheumatoid arthritis (RA) at risk of infection from pneumonia, according to the results of a clinical trial in Japan. The study ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.